Related Experiment Video
Updated: Jun 10, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Clinical determinants of aspirin resistance in diabetes
Hussein N Yassine1, Grace Davis-Gorman, Craig S Stump
1Department of Medicine, Division of Endocrinology, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA. hyassine@email.arizona.edu
Abstract:
Recent studies indicate that not all diabetic subjects benefit from aspirin therapy. Our objective is to characterize diabetic subjects with aspirin resistance using urine thromboxane, and VerifyNow measures. Our results suggest that cardiovascular disease, microalbuminuria, poor diabetes control, and increased waist circumference help identify aspirin resistance in diabetes.
Related Concept Videos
Drug Toxicity: Risk factors
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Type II Diabetes I: Introduction
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Type 2 and Gestational
Drug toxicity: Drug–Drug Interaction